Healthcare -
Biotechnology - NASDAQ - US
$ 9.135
-2.82 %
$ 774 M
Market Cap
-1.15
P/E
IMNM - TOTAL CURRENT LIABILITIES
Total Current Liabilities IMNM - Immunome, Inc.
21.8 M
LAST VALUE
49.80%
2 YEAR CAGR
69.48%
5 YEAR CAGR
0.00%
10 YEAR CAGR